Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure

J Thorac Oncol. 2007 Jan;2(1):96-8. doi: 10.1097/JTO.0b013e31802bffb0.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Carcinoma, Non-Small-Cell Lung / complications
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • ErbB Receptors / antagonists & inhibitors*
  • Erlotinib Hydrochloride
  • Female
  • Humans
  • Kidney Failure, Chronic / complications*
  • Kidney Failure, Chronic / metabolism
  • Lung Neoplasms / complications
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Palliative Care
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / adverse effects
  • Quinazolines / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors